Artículos de revistas sobre el tema "Virus diseases – Chemotherapy"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Virus diseases – Chemotherapy".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Talib Al-Nafakh, Rana. "Epstein–Barr Virus and Rheumatoid Arthritis in Cancer Patients Undergoing Chemotherapy in Al-Najaf Province, Iraq". Journal of Communicable Diseases 55, n.º 04 (13 de marzo de 2024): 119–25. http://dx.doi.org/10.24321/0019.5138.202364.
Texto completoRollinson, E. A. "Prospects for Antiviral Chemotherapy in Veterinary Medicine: 1. Feline Virus Diseases". Antiviral Chemistry and Chemotherapy 3, n.º 5 (octubre de 1992): 249–62. http://dx.doi.org/10.1177/095632029200300501.
Texto completoSnoeck, R., G. Andrei y E. De Clercq. "Chemotherapy of varicella zoster virus infections". International Journal of Antimicrobial Agents 4, n.º 3 (agosto de 1994): 211–26. http://dx.doi.org/10.1016/0924-8579(94)90011-6.
Texto completoPolsky, Bruce. "Antiviral Chemotherapy for Infection with Human Immunodeficiency Virus". Clinical Infectious Diseases 11, Supplement_7 (1 de noviembre de 1989): S1648—S1663. http://dx.doi.org/10.1093/clinids/11.supplement_7.s1648.
Texto completoRice, W. G. y J. A. Turpin. "Virus-encoded Zinc Fingers as Targets for Antiviral Chemotherapy". Reviews in Medical Virology 6, n.º 4 (diciembre de 1996): 187–99. http://dx.doi.org/10.1002/(sici)1099-1654(199612)6:4<187::aid-rmv176>3.0.co;2-f.
Texto completoFIELD, HUGH J. "The impact of drug resistance upon virus chemotherapy". Journal of Antimicrobial Chemotherapy 24, n.º 1 (1989): 4–7. http://dx.doi.org/10.1093/jac/24.1.4.
Texto completoHan, Seung Beom, Hye Jo Shin, Eui Soo Lee, Jae Wook Lee, Nack-Gyun Chung, Bin Cho y Jin Han Kang. "SEROLOGICAL CHANGES AGAINST HEPATITIS B SURFACE ANTIGEN IN CHILDREN AND ADOLESCENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIA". Mediterranean Journal of Hematology and Infectious Diseases 11, n.º 1 (29 de agosto de 2019): e2019052. http://dx.doi.org/10.4084/mjhid.2019.052.
Texto completoWainberg, Mark A., Andre Dascal y Jack Mendelson. "Anti-Retroviral Strategies for AIDS and Related Diseases". Canadian Journal of Infectious Diseases 2, n.º 3 (1991): 121–28. http://dx.doi.org/10.1155/1991/487657.
Texto completoBenke, Ashwini Prashant, Ram Krishna, Kiran Khandagale, Suresh Gawande, Poonam Shelke, Somnath Dukare, Sweta Dhumal, Major Singh y Vijay Mahajan. "Efficient Elimination of Viruses from Garlic Using a Combination of Shoot Meristem Culture, Thermotherapy, and Chemical Treatment". Pathogens 12, n.º 1 (12 de enero de 2023): 129. http://dx.doi.org/10.3390/pathogens12010129.
Texto completoDorobantu, Cristina M., Christian Harak, Rahel Klein, Lonneke van der Linden, Jeroen R. P. M. Strating, Hilde M. van der Schaar, Volker Lohmann y Frank J. M. van Kuppeveld. "Tyrphostin AG1478 Inhibits Encephalomyocarditis Virus and Hepatitis C Virus by Targeting Phosphatidylinositol 4-Kinase IIIα". Antimicrobial Agents and Chemotherapy 60, n.º 10 (1 de agosto de 2016): 6402–6. http://dx.doi.org/10.1128/aac.01331-16.
Texto completoPatel, R. y S. E. Barton. "Antiviral Chemotherapy in Genital Herpes Simplex Virus Infections". International Journal of STD & AIDS 6, n.º 5 (septiembre de 1995): 320–28. http://dx.doi.org/10.1177/095646249500600503.
Texto completoRoy, Biswajit G. "Potential of small-molecule fungal metabolites in antiviral chemotherapy". Antiviral Chemistry and Chemotherapy 25, n.º 2 (23 de julio de 2017): 20–52. http://dx.doi.org/10.1177/2040206617705500.
Texto completoDe Clercq, Erik. "Acyclic Nucleoside Phosphonates in the Chemotherapy of DNA Virus and Retrovirus Infections". Intervirology 40, n.º 5-6 (1997): 295–303. http://dx.doi.org/10.1159/000150563.
Texto completoYeo, Winnie, Joyce L. Steinberg, John S. Tam, Paul K. S. Chan, Nancy W. Y. Leung, Kwok C. Lam, Tony S. K. Mok y Philip J. Johnson. "Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy". Journal of Medical Virology 59, n.º 3 (noviembre de 1999): 263–69. http://dx.doi.org/10.1002/(sici)1096-9071(199911)59:3<263::aid-jmv1>3.0.co;2-x.
Texto completoRollinson, E. A. "Prospects for Antiviral Chemotherapy in Veterinary Medicine: 2. Avian, Piscine, Canine, Porcine, Bovine and Equine Virus Diseases". Antiviral Chemistry and Chemotherapy 3, n.º 6 (diciembre de 1992): 311–26. http://dx.doi.org/10.1177/095632029200300601.
Texto completoHirsch, M. S. "Chemotherapy of Human Immunodeficiency Virus Infections: Current Practice and Future Prospects". Journal of Infectious Diseases 161, n.º 5 (1 de mayo de 1990): 845–57. http://dx.doi.org/10.1093/infdis/161.5.845.
Texto completoDylewski, J. y L. Thibert. "Failure of Tuberculosis Chemotherapy in a Human Immunodeficiency Virus-Infected Patient". Journal of Infectious Diseases 162, n.º 3 (1 de septiembre de 1990): 778–79. http://dx.doi.org/10.1093/infdis/162.3.778.
Texto completoHenrich, Timothy J., Kristen S. Hobbs, Emily Hanhauser, Eileen Scully, Louise E. Hogan, Yvonne P. Robles, Kaitlyn S. Leadabrand et al. "Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy". Journal of Infectious Diseases 216, n.º 2 (3 de junio de 2017): 254–62. http://dx.doi.org/10.1093/infdis/jix265.
Texto completoThackray, Alana M. y Hugh J. Field. "Persistence of Infectious Herpes Simplex Virus Type 2 in the Nervous System in Mice after Antiviral Chemotherapy". Antimicrobial Agents and Chemotherapy 44, n.º 1 (1 de enero de 2000): 97–102. http://dx.doi.org/10.1128/aac.44.1.97-102.2000.
Texto completoIdilman, R., M. Arat, E. Soydan, M. Toruner, I. Soykan, H. Akbulut, O. Arslan et al. "Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies". Journal of Viral Hepatitis 11, n.º 2 (marzo de 2004): 141–47. http://dx.doi.org/10.1046/j.1365-2893.2003.00479.x.
Texto completoTien Phat, Do, Pham Bich Ngoc y Chu Hoang Ha. "Methods to manage, protect and improve plant virus resistance". Vietnam Journal of Biotechnology 19, n.º 4 (3 de mayo de 2022): 607–18. http://dx.doi.org/10.15625/1811-4989/15584.
Texto completoOketani, Makoto, Akio Ido, Hirofumi Uto y Hirohito Tsubouchi. "Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy". Hepatology Research 42, n.º 7 (12 de junio de 2012): 627–36. http://dx.doi.org/10.1111/j.1872-034x.2012.00998.x.
Texto completoLocasciulli, A., M. Santamaria, G. Masera, E. Schiavon, A. Alberti y G. Realdi. "Hepatitis B virus markers in children with acute leukemia: The effect of chemotherapy". Journal of Medical Virology 15, n.º 1 (enero de 1985): 29–33. http://dx.doi.org/10.1002/jmv.1890150105.
Texto completoYeo, Winnie, Paul K. S. Chan, Henry L. Y. Chan, Frankie K. F. Mo y Philip J. Johnson. "Hepatitis B virus reactivation during cytotoxic chemotherapy-enhanced viral replication precedes overt hepatitis". Journal of Medical Virology 65, n.º 3 (2001): 473–77. http://dx.doi.org/10.1002/jmv.2060.
Texto completoDe Clercq, Erik. "Perspectives for the chemotherapy of respiratory syncytial virus (RSV) infections". International Journal of Antimicrobial Agents 7, n.º 3 (agosto de 1996): 193–202. http://dx.doi.org/10.1016/s0924-8579(96)00319-6.
Texto completoIshii, T., M. Hosoya, S. Mori, S. Shigeta y H. Suzuki. "Effective ribavirin concentration in hamster brains for antiviral chemotherapy for subacute sclerosing panencephalitis." Antimicrobial Agents and Chemotherapy 40, n.º 1 (enero de 1996): 241–43. http://dx.doi.org/10.1128/aac.40.1.241.
Texto completoCingarlini, Sara. "Unusual Presentations for EBV and HHV8 Co-Infections: A Case Report and Review of Literature". Journal of Clinical Case Studies Reviews & Reports 5, n.º 9 (30 de septiembre de 2023): 1–6. http://dx.doi.org/10.47363/jccsr/2023(5)258.
Texto completoZumla, A. y S. L. Croft. "Chemotherapy and immunity in opportunistic parasitic infections in AIDS". Parasitology 105, S1 (enero de 1992): S93—S101. http://dx.doi.org/10.1017/s0031182000075405.
Texto completoIlyushina, Natalia A., Erich Hoffmann, Rachelle Salomon, Robert G. Webster y Elena A. Govorkova. "Amantadine-Oseltamivir Combination therapy for H5N1 Influenza Virus Infection in Mice". Antiviral Therapy 12, n.º 3 (1 de abril de 2006): 363–70. http://dx.doi.org/10.1177/135965350701200302.
Texto completoSjöberg, Anita Herrström, Liya Wang y Staffan Eriksson. "Antiviral Guanosine Analogs as Substrates for Deoxyguanosine Kinase: Implications for Chemotherapy". Antimicrobial Agents and Chemotherapy 45, n.º 3 (1 de marzo de 2001): 739–42. http://dx.doi.org/10.1128/aac.45.3.739-742.2001.
Texto completoYeo, Winnie, Paul K. S. Chan, Pun Hui, Wing M. Ho, Kwok C. Lam, Wing H. Kwan, Sheng Zhong y Philip J. Johnson. "Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: A prospective study". Journal of Medical Virology 70, n.º 4 (2 de junio de 2003): 553–61. http://dx.doi.org/10.1002/jmv.10430.
Texto completoChen, Jungang, Samantha Kendrick y Zhiqiang Qin. "Mechanistic Insights into Chemoresistance Mediated by Oncogenic Viruses in Lymphomas". Viruses 11, n.º 12 (16 de diciembre de 2019): 1161. http://dx.doi.org/10.3390/v11121161.
Texto completoZon, Robin T. y Michael N. Neuss. "ASCO Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases". Journal of Oncology Practice 6, n.º 4 (julio de 2010): 193–94. http://dx.doi.org/10.1200/jop.777007.
Texto completoUchiyama, Michihiro, Yotaro Tamai y Takashi Ikeda. "Entecavir as prophylaxis against hepatitis B virus reactivation following chemotherapy for lymphoma". International Journal of Infectious Diseases 14, n.º 3 (marzo de 2010): e265-e266. http://dx.doi.org/10.1016/j.ijid.2009.04.014.
Texto completoKorzh, Elena V. "Interstitial lung diseases in persons infected with human immunodeficiency virus". PULMONOLOGIYA 33, n.º 6 (13 de diciembre de 2023): 841–48. http://dx.doi.org/10.18093/0869-0189-2023-33-6-841-848.
Texto completoGreiner, Timothy, James O. Armitage y Thomas G. Gross. "Atypical Lymphoproliferative Diseases". Hematology 2000, n.º 1 (1 de enero de 2000): 133–46. http://dx.doi.org/10.1182/asheducation.v2000.1.133.133.
Texto completoGreiner, Timothy, James O. Armitage y Thomas G. Gross. "Atypical Lymphoproliferative Diseases". Hematology 2000, n.º 1 (1 de enero de 2000): 133–46. http://dx.doi.org/10.1182/asheducation.v2000.1.133.20000133.
Texto completoKOTLYAR, V. K., S. V. FEDOROVICH y O. L. SEGET. "IMPROVEMENT OF GRAPE CUTTINGS BY THERMOTHERAPY AGAINST GLRAV-3 VIRUS". Scientific Works of North Caucasian Federal Scientific Center of Horticulture Viticulture Wine-making 37 (septiembre de 2023): 107–10. http://dx.doi.org/10.30679/2587-9847-2023-37-107-110.
Texto completoNowak, J. S. y D. Januszkiewicz. "CHEMOTHERAPY OF CHILDREN WITH LYMPHOPROLIFERATIVE DISEASES AS A RISK FACTOR FOR HEPATITIS C VIRUS INFECTION. 127". Pediatric Research 41, n.º 5 (mayo de 1997): 770. http://dx.doi.org/10.1203/00006450-199705000-00146.
Texto completoRamphal, Raveena, Ronald M. Grant, Biljana Dzolganovski, Julie Constantin, Raymond Tellier, Upton Allen, Sheila Weitzman, Anne Matlow, Martin Petric y Lillian Sung. "Herpes Simplex Virus in Febrile Neutropenic Children Undergoing Chemotherapy for Cancer". Pediatric Infectious Disease Journal 26, n.º 8 (agosto de 2007): 700–704. http://dx.doi.org/10.1097/inf.0b013e31805cdc11.
Texto completoNishida, Tsutomu, Naoki Hiramatsu, Masao Mizuki, Izumi Nagatomo, Hiroshi Kida, Keiko Tazumi, Shinichiro Shinzaki et al. "Managing hepatitis B virus carriers with systemic chemotherapy or biologic therapy in the outpatient clinic". Hepatology Research 43, n.º 4 (6 de agosto de 2012): 339–46. http://dx.doi.org/10.1111/j.1872-034x.2012.01073.x.
Texto completoShahgolzari, Mehdi, Srividhya Venkataraman, Anne Osano, Paul Achile Akpa y Kathleen Hefferon. "Plant Virus Nanoparticles Combat Cancer". Vaccines 11, n.º 8 (25 de julio de 2023): 1278. http://dx.doi.org/10.3390/vaccines11081278.
Texto completoPolyakov, Yu Yu, E. A. Baryakh, E. N. Misyurina, E. I. Zhelnova, M. A. Mingalimov, S. A. Kardovskaya, M. Ya Smolyarchuk et al. "Persistence of a new coronavirus infection in a patient with primary central nervous system large B-cell lymphoma with assessment of the humoral immune response against SARS-CoV-2". Oncohematology 19, n.º 2 (2 de abril de 2024): 101–8. http://dx.doi.org/10.17650/1818-8346-2024-19-2-101-108.
Texto completoIslas-Muñoz, B., B. Méndez-Sotelo, J. Reyes-Pérez, M. Jiménez-de los Santos, R. Herrera-Goepfert y P. Volkow-Fernández. "Obstructive cholangiopathy patient caused by cytomegalovirus and Kaposi sarcoma in a person living with HIV and hepatitis C". International Journal of STD & AIDS 31, n.º 11 (4 de agosto de 2020): 1110–13. http://dx.doi.org/10.1177/0956462420943027.
Texto completoLi, Shu, Xiao-Yu Liu, Qiu Pan, Jian Wu, Zhi-Hao Liu, Yong Wang, Min Liu y Xiao-Lian Zhang. "Hepatitis C Virus-Induced FUT8 Causes 5-FU Drug Resistance in Human Hepatoma Huh7.5.1 Cells". Viruses 11, n.º 4 (24 de abril de 2019): 378. http://dx.doi.org/10.3390/v11040378.
Texto completoCastelli, Roberto, Riccardo Schiavon, Carlo Preti y Laurenzia Ferraris. "HIV-Related Lymphoproliferative Diseases in the Era of Combination Antiretroviral Therapy". Cardiovascular & Hematological Disorders-Drug Targets 20, n.º 3 (26 de noviembre de 2020): 175–80. http://dx.doi.org/10.2174/1871529x20666200415121009.
Texto completoPham, Hoang. "Mathematical Modeling the Time-Delay Interactions between Tumor Viruses and the Immune System with the Effects of Chemotherapy and Autoimmune Diseases". Mathematics 10, n.º 5 (27 de febrero de 2022): 756. http://dx.doi.org/10.3390/math10050756.
Texto completoPuig-Basagoiti, Francesc, Tia S. Deas, Ping Ren, Mark Tilgner, David M. Ferguson y Pei-Yong Shi. "High-Throughput Assays Using a Luciferase-Expressing Replicon, Virus-Like Particles, and Full-Length Virus for West Nile Virus Drug Discovery". Antimicrobial Agents and Chemotherapy 49, n.º 12 (diciembre de 2005): 4980–88. http://dx.doi.org/10.1128/aac.49.12.4980-4988.2005.
Texto completoBeck, Sungjun, Zhe Zhu, Michelli F. Oliveira, Davey M. Smith, Jeremy N. Rich, Jean A. Bernatchez y Jair L. Siqueira-Neto. "Mechanism of Action of Methotrexate Against Zika Virus". Viruses 11, n.º 4 (10 de abril de 2019): 338. http://dx.doi.org/10.3390/v11040338.
Texto completoLoginova, S. Ya, V. N. Schukina, S. V. Savenko, R. V. Sakharov y S. V. Borisevich. "Study of the Activity of Antiviral Drugs Against the Causative Agent of Chikungunya Fever in Cell Culture". Antibiotics and Chemotherapy 67, n.º 11-12 (11 de febrero de 2023): 10–15. http://dx.doi.org/10.37489/0235-2990-2022-67-11-12-10-15.
Texto completo